95 related articles for article (PubMed ID: 9815615)
1. Isolated limb perfusion in the sarcoma-bearing rat: a novel preclinical gene delivery system.
Milas M; Feig B; Yu D; Oriuchi N; Cromeens D; Ge T; Wong FC; Kim EE; Pollock R
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2197-203. PubMed ID: 9815615
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.
Hannay J; Davis JJ; Yu D; Liu J; Fang B; Pollock RE; Lev D
Gene Ther; 2007 Apr; 14(8):671-81. PubMed ID: 17287860
[TBL] [Abstract][Full Text] [Related]
3. Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas.
de Roos WK; de Wilt JH; van Der Kaaden ME; Manusama ER; de Vries MW; Bout A; ten Hagen TL; Valerio D; Eggermont AM
Ann Surg; 2000 Dec; 232(6):814-21. PubMed ID: 11088076
[TBL] [Abstract][Full Text] [Related]
4. Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
Pencavel TD; Wilkinson MJ; Mansfield DC; Khan AA; Seth R; Karapanagiotou EM; Roulstone V; Aguilar RJ; Chen NG; Szalay AA; Hayes AJ; Harrington KJ
Int J Cancer; 2015 Feb; 136(4):965-76. PubMed ID: 24978211
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a microprocessor controlled extracorporal circuit in rats for the optimization of isolated limb perfusion.
Gürtler U; Fuchs P; Stangelmayer A; Bernhardt G; Buschauer A; Spruss T
Arch Pharm (Weinheim); 2004 Dec; 337(12):672-81. PubMed ID: 15597400
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
Deroose JP; Eggermont AM; van Geel AN; Burger JW; den Bakker MA; de Wilt JH; Verhoef C
J Clin Oncol; 2011 Oct; 29(30):4036-44. PubMed ID: 21931039
[TBL] [Abstract][Full Text] [Related]
7. The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.
Ten Hagen TL; Seynhaeve AL; de Wiel-Ambagtsheer Ga; de Bruijn EA; van Tiel ST; Ruegg C; Meyring M; Grell M; Goodman SL; Eggermont AM
Int J Cancer; 2013 Jun; 132(11):2694-704. PubMed ID: 23152080
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats.
de Wilt JH; Bout A; Eggermont AM; van Tiel ST; de Vries MW; ten Hagen TL; de Roos WK; Valerio D; van der Kaaden ME
Hum Gene Ther; 2001 Mar; 12(5):489-502. PubMed ID: 11268282
[TBL] [Abstract][Full Text] [Related]
9. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan.
Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL
Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360
[TBL] [Abstract][Full Text] [Related]
10. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
Alegre JF; Duarte M; Sureda González M; Bretcha Boix P; Dussan C; Ballester A; Crespo A; Brugarolas Masllorens A
Cir Esp; 2012 Feb; 90(2):114-20. PubMed ID: 22225611
[TBL] [Abstract][Full Text] [Related]
11. The role of hyperthermia in regional alkylating agent chemotherapy.
Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
[TBL] [Abstract][Full Text] [Related]
12. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.
Hoving S; Brunstein F; aan de Wiel-Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
Cancer Res; 2005 May; 65(10):4300-8. PubMed ID: 15899822
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.
Kubo T; Shimose S; Matsuo T; Fujimori J; Sakaguchi T; Yamaki M; Shinozaki K; Woo SL; Ochi M
J Orthop Res; 2011 May; 29(5):795-800. PubMed ID: 21437961
[TBL] [Abstract][Full Text] [Related]
15. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.
Colombo C; Baratti D; Kusamura S; Deraco M; Gronchi A
J Surg Oncol; 2015 Apr; 111(5):570-9. PubMed ID: 25351775
[TBL] [Abstract][Full Text] [Related]
16. Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.
Eggermont AM; Schraffordt Koops H; Klausner JM; Liénard D; Kroon BB; Schlag PM; Ben-Ari G; Lejeune FJ
Semin Oncol; 1997 Oct; 24(5):547-55. PubMed ID: 9344321
[TBL] [Abstract][Full Text] [Related]
17. Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy.
Brooks AD; Ng B; Liu D; Brownlee M; Burt M; Federoff HJ; Fong Y
Surgery; 2001 Mar; 129(3):324-34. PubMed ID: 11231461
[TBL] [Abstract][Full Text] [Related]
18. The role of regional chemotherapy in the management of extremity soft tissue malignancies.
Smith HG; Hayes AJ
Eur J Surg Oncol; 2016 Jan; 42(1):7-17. PubMed ID: 26382102
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
20. [Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs].
Abu-Abid S; Gutman M; Lev D; Inbar M; Chaitchik S; Sorkine P; Rudick V; Meller I; Klausner JM
Harefuah; 1996 Oct; 131(7-8):227-32, 296, 295. PubMed ID: 8940515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
